Mutations in the gene for familial mediterranean fever: Do they predispose to inflammation?

Journal of Rheumatology

Volumn 30, Issue 9, 2003, Pages 2014-2018

  Ozen, Seza ^a   Bakkaloglu, Aysin ^b   Yilmaz, Engin ^b   Duzova, Ali ^b   Balci, Banu ^b   Topaloglu, Rezan ^b   Besbas, Nesrin ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE

Author keywords

Carrier frequency; Familial mediterranean fever; Juvenile arthritis

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL PAIN; ACUTE PHASE RESPONSE; ALLELE; ARTICLE; BEHCET DISEASE; CHILD; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATIC FEVER; VASCULITIS;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFLAMMATION; MALE; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; PROBABILITY; PROSPECTIVE STUDIES; PROTEINS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 0043195798     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Samuels J, Aksentijevich I, Torosyan Y, et al. FMF at the Millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine 1998;77:268-97.
2. Ben-Chetrit E. Levy M. Enigmas in FMF. Clin Exp Rheumatol 2001;19:s1-s5.
3. Ozen S. Vasculopathy, Behçet's disease and familial Mediterranean fever. Curr Opin Rheumatol 1999;11:393-8.
4. Kastner DL. FMF: The genetics of inflammation. Hosp Prac 1998;33:131-58.
5. Cazaneuve C, Ajrapetyan H, Papin S, et al. Identification of MEFV-independent modifying genetic factors for FMF. Am J Hum Genet 2000;67:1136-43.
6. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of FMF. Arthritis Rheum 1997;40:1879-85.
7. Livneh A, Langevitz P, Zemer D, et al. Establishment of a new set of criteria for the classification of FMF. In: Sohar E, Gafni J, Pras M, editors. Familial Mediterranean fever. London: Freund Publishing House; 1997:203-8.
8. Kogan A, Shinar Y, Lidar M, et al. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 2001;102:272-6.
9. Touitou I. The spectrum of FMF mutations. Eur J Hum Genet 2001;9:473-83.
10. Aksentijevich I, Samuels J, Centola M, et al. Mutation and haplotype studies of FMF reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Askhenazi Jewish population. Am J Hum Genet 1999;64:949-62.
11. Yilmaz E, Ozen S, Balci B, et al. Mutation frequency of FMF and evidence of a high carrier rate in the Turkish population. Eur J Hum Genet 2001;9:553-5.
12. Daniels M, Shohat T, Brenner-Ullman A, Shohat M, FMF: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel. Am J Med Genet 1995;55:311-4.
13. Ozen S, Balci B, Ozkara S, et al. Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculosis infections? Speculations remain. Clin Exp Rheumatol 2002;20:S57-8.
14. Tunca M, Kirkali G, Soytuk M, Akar S, Pepys M, Hawkins P. Acute phase response and evolution of FMF [letter]. Lancet 1999;353:1415.
15. Booth DR, Lachmann HJ, Gillmore JD, Booth SE, Hawkins PN. Prevalence and significance of the FMF gene mutation encoding pyrin Q148. QJM 2001;94:527-31.
16. Petty RE, Southwood TR, Baum J, et al. Revision of proposed classification criteria for juvenile idiopathic arthritis: Durban 1997. J Rheumatol 1998;25:1991-5.
17. International study group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1070-80.
18. Ozen S, Besbas N, Bakkaloglu A, Yilmaz E. Pyrin 148Q does cause clinical FMF. QJM 2002;95:332-3.
19. Akarsu N, Ozen S, Saatci U, Bakkaloglu A, Besbas N. Sarfarazi M. Genetic linkage study of FMF to 16p13.3 and evidence for genetic heterogeneity in the Turkish population. J Med Genet 1997;34:573-8.
20. Ozen S, Ben-Chetrit E, Bakkaloglu A, et al. PAN in patients with FMF: a concomitant disease or a feature of FMF? Semin Arthritis Rheum 2001;30:281-7.
21. Aypar E, Ozen S, Okur H, et al. TH1 polarization in FMF (submitted for publication).
22. Ben-Chetrit E, Cohen R, Chajek-Shaul T. FMF and Behçet's disease - are they associated? J Rheumatol 2002;29:530-4.
23. Touitou I, Magne X, Molinari N, et al. MEFV mutations in Beḩet's diseaae. Hum Mutat 2000;16:271-2.
24. Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A. Behçet's disease in FMF: Characterization of the association between the two diseases. Semin Arthritis Rheum 2000;29:286-9